Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum Book of Abstracts - Ruhr-Universität Bochum
P-59 ISBOMC `10 5.7 – 9.7. 2010 Ruhr-Universität Bochum Synthesis, Characterization and Properties of the Cluster Rhenium(ІІІ) Compound with β-Alanine Ligands Mariia S. Randarevych, a Kateryna A. Zablotska, a Konstantin V. Domasevitch, b Alexander V. Shtemenko a a Department of Inorganic Chemistry, Ukrainian State Chemical Technological University, Gagarin Ave. 8, Dnipropetrovs’k 49005, Ukraine. E-mail: shtemenko@ukr.net. b Department of Inorganic Chemistry, Kiev University, Volodimirska Street 64, Kiev 01033, Ukraine. E-mail: dk@univ.kiev.ua. The theoretical interest in binuclear complex compounds of dirhenium(ІІІ) is caused by the fact that rhenium is one of the few elements that are able to form a multiplet metal-metal bond. From the practical point of view, these compounds can be used in medical practice since they have anticancerogenic, antihemolytic, and antiradical properties and lower toxicity in comparison with other well-known compounds of transition metals. One of the received cluster compounds of dirhenium(ІІІ) with γ-aminobutyric acid’s ligands has already shown excellent antitumor properties. 1 Owing to this, our purpose is to expand the range of similar compounds by using other amino acids as ligands which possess own biological activity. Therefore, the synthesis of new cluster aminocarboxylates of dirhenium(III) and the study of their physicochemical and biological properties are of great interest for us. A synthetic procedure of dirhenium(ІІІ) complex compound with β-alanine was developed. The properties of this compound are investigated by spectral method. The compound cis-Re2Cl6{�-AlaH}2 ·1.5H2O is shown to consist of coordinating centre Re2 6 + with quadruple bond rhenium-rhenium. In equatorial positions there are bridge groups containing β-alanine residues being in cys-position relative to Re-Re. The structure of the given compound is presented on fig. 1. Fig.1 cis-Re2Cl6{�-AlaH}2 ·1.5H2O The structure of this compound is confirmed by direct X-ray structure, thermal and spectral analyses. We have also investigated the biological activity of the complex that revealed itself perspective as a cytostatic and anticancer agent. References 1. A. Shtemenko, P. Collery, N. Shtemenko, K. Domasevitch, E. Zabitskaya, A. Golichenko Dalton Trans. 2009, 26, 5132 - 5136. 117
P-60 ISBOMC `10 5.7 – 9.7. 2010 Ruhr-Universität Bochum Exploring Histidines as Biomolecular Anchors to Re(CO)3 + Richard S. Herrick, a Christopher J. Ziegler, b Roger Rowlett, Americo Gambella a a College of the Holy Cross, Department of Chemistry, 1 College St., Worcester, MA 01610, USA. b University of Akron, Department of Chemistry, KNCL 402, Akron, OH 444325, USA. c Department of Chemistry, Colgate University, 13 Oak Drive, Hamilton, NY 13346 (USA). E-mail: rherrick@holycross.edu In recent years we have explored the potential of using amino acids and amino acid conjugates to bind Re(CO)3 + . We are currently exploring the use of histidine-containing peptide conjugates as models of His-tags in order to test their ability to bind the Re(CO)3 + . His-OMe, Ac-His-OH and His-His-OH were each exposed to aqueous solution of Re(CO)3 + . Reaction with His-OMe lead to ester cleavage and formation of the previously observed Re(CO)3(� 3 -N�,N�,O - -His). Reactions with Ac-His-OH and His-His-OH each led to novel compounds containing a carboxamido N-donor group. The characterization, including X-ray crystallography, of each compound, and testing of each compounds ability to withstand challenge experiments will be discussed. We have also been interested in using proteins to bind Re(CO)3 + . Little work has been carried out on reactions between rhenium prodrug or drug model complexes and proteins. Such interactions can be crucial to the biological processing of Tc/Re based imaging agents, since proteins, rather than nucleotides or single amino acids, would be encountered in plasma. Alternatively, protein-Tc/Re adducts could be novel targets for use as imaging or therapeutic agents. In order to probe this chemistry, we are examining the interactions between Re(CO)3(H2O)3 + and the readily crystallizable protein lysozyme. A crystal structure has been obtained of a lysozyme-Re(CO)3(H2O)2 adduct. Experimental details, including the new crystal structure, will be discussed. From these studies highlighting the binding of histidines in peptides and proteins to Re(CO)3(H2O)3 + , several conclusions can be drawn. These will be discussed along with future directions of this research. 118
- Page 67 and 68: P-08 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 69 and 70: P-10 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 71 and 72: P-12 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 73 and 74: P-14 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 75 and 76: P-16 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 77 and 78: P-18 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 79 and 80: P-20 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 81 and 82: P-22 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 83 and 84: P-24 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 85 and 86: P-26 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 87 and 88: P-28 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 89 and 90: P-30 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 91 and 92: P-32 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 93 and 94: P-34 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 95 and 96: P-36 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 97 and 98: P-38 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 99 and 100: P-40 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 101 and 102: P-42 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 103 and 104: P-44 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 105 and 106: P-46 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 107 and 108: P-48 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 109 and 110: P-50 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 111 and 112: P-52 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 113 and 114: P-54 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 115 and 116: P-56 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 117: P-58 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 121 and 122: P-62 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 123 and 124: P-64 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 125 and 126: P-66 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 127 and 128: P-68 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 129 and 130: P-70 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 131 and 132: P-72 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 133 and 134: P-74 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 135 and 136: P-76 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 137 and 138: P-78 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 139 and 140: P-80 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 141 and 142: P-82 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 143 and 144: P-84 ISBOMC `10 5.7 - 9.7. 2010 Ruh
- Page 145 and 146: Sergey Abramkin Universität Wien,
- Page 147 and 148: Tensim Dallagi ENSCP, France t.dall
- Page 149 and 150: Prof. Dr. Toshikazu Hirao Osaka Uni
- Page 151 and 152: ISBOMC `10 5.7 - 9.7. 2010 Ruhr-Uni
- Page 153 and 154: Obiora Augustine Orakwue Hyqid Nige
- Page 155 and 156: ISBOMC `10 5.7 - 9.7. 2010 Ruhr-Uni
- Page 157: ISBOMC `10 5.7 - 9.7. 2010 Ruhr-Uni
P-60<br />
ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />
Exploring Histidines as Biomolecular Anchors to Re(CO)3 +<br />
Richard S. Herrick, a Christopher J. Ziegler, b Roger Rowlett, Americo Gambella a<br />
a College <strong>of</strong> the Holy Cross, Department <strong>of</strong> Chemistry, 1 College St., Worcester, MA 01610, USA.<br />
b University <strong>of</strong> Akron, Department <strong>of</strong> Chemistry, KNCL 402, Akron, OH 444325, USA. c Department<br />
<strong>of</strong> Chemistry, Colgate University, 13 Oak Drive, Hamilton, NY 13346 (USA).<br />
E-mail: rherrick@holycross.edu<br />
In recent years we have explored the potential <strong>of</strong> using amino acids and amino acid conjugates to bind<br />
Re(CO)3 + . We are currently exploring the use <strong>of</strong> histidine-containing peptide conjugates as models <strong>of</strong><br />
His-tags in order to test their ability to bind the Re(CO)3 + . His-OMe, Ac-His-OH and His-His-OH<br />
were each exposed to aqueous solution <strong>of</strong> Re(CO)3 + . Reaction with His-OMe lead to ester cleavage<br />
and formation <strong>of</strong> the previously observed Re(CO)3(� 3 -N�,N�,O - -His). Reactions with Ac-His-OH and<br />
His-His-OH each led to novel compounds containing a carboxamido N-donor group. The<br />
characterization, including X-ray crystallography, <strong>of</strong> each compound, and testing <strong>of</strong> each compounds<br />
ability to withstand challenge experiments will be discussed.<br />
We have also been interested in using proteins to bind Re(CO)3 + . Little work has been carried out on<br />
reactions between rhenium prodrug or drug model complexes and proteins. Such interactions can be<br />
crucial to the biological processing <strong>of</strong> Tc/Re based imaging agents, since proteins, rather than<br />
nucleotides or single amino acids, would be encountered in plasma. Alternatively, protein-Tc/Re<br />
adducts could be novel targets for use as imaging or therapeutic agents. In order to probe this<br />
chemistry, we are examining the interactions between Re(CO)3(H2O)3 + and the readily crystallizable<br />
protein lysozyme. A crystal structure has been obtained <strong>of</strong> a lysozyme-Re(CO)3(H2O)2 adduct.<br />
Experimental details, including the new crystal structure, will be discussed.<br />
From these studies highlighting the binding <strong>of</strong> histidines in peptides and proteins to Re(CO)3(H2O)3 + ,<br />
several conclusions can be drawn. These will be discussed along with future directions <strong>of</strong> this<br />
research.<br />
118